Replies to post #187827 on Anavex Life Sciences Corp (AVXL)

[kevli33]

The P-2a AD study which is now an extension study of the initial 32 patients and lasting now 208 weeks, which was initially a PK study lasting for 5 weeks and then has been extended thereafter in multiple occasions now reaching full 5 year, over 5 year period of observing safety and also exploratory efficacy.

Wow...seeing that number again and again....come on Aussies...citizens...think of your fellow citizens.

Anavex Now!

[TempePhil]

Thanks Tradeher. That gives some context to the PD request. Not really indicative of improvement being seen, but maybe! Imho